Lexaria Bioscience Corp.
Lexaria Bioscience Corp. (LEXX) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 20 transactions totaling $147.3K, demonstrating a bullish sentiment with $126.8K in net insider flow. The most recent transaction on Jul 30, 2025 involved a purchase of 11,900 shares valued at $10.8K.
LEXX Insider Activity Summary
Who Is Buying LEXX Stock?
No significant insider buying has been recorded for LEXX in the recent period.
Who Is Selling LEXX Stock?
No significant insider selling has been recorded for LEXX in the recent period.
Is Lexaria Bioscience Corp. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for LEXX is bullish with an Insider Alignment Score of 93/100 and a net flow of $126.8K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
LEXX Frequently Asked Questions
Understanding LEXX Insider Activity
Insider trading at Lexaria Bioscience Corp. (LEXX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading LEXX stock, having executed 20 transactions in the past 90 days. The most active insider is Christopher Bunka (Executive), who has made 6 transactions totaling $182.1K.
Related Tools
Track Lexaria Bioscience Corp. Insider Activity
Get notified when executives and directors at LEXX file new Form 4 transactions